A Selenite pentahydrate, Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Selenite pentahydrate, Sodium Certificate of Suitability (COS). The purpose of a Selenite pentahydrate, Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Selenite pentahydrate, Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Selenite pentahydrate, Sodium to their clients by showing that a Selenite pentahydrate, Sodium CEP has been issued for it. The manufacturer submits a Selenite pentahydrate, Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Selenite pentahydrate, Sodium CEP holder for the record. Additionally, the data presented in the Selenite pentahydrate, Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Selenite pentahydrate, Sodium DMF.
A Selenite pentahydrate, Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Selenite pentahydrate, Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Selenite pentahydrate, Sodium suppliers with CEP (COS) on PharmaCompass.